Drug Discovery · San Francisco, CA · Founded 2023 · Privately Held (backing)
Developer of a programmable technology designed to deliver messenger ribonucleic acid to diverse cell types in the body. ParcelBio is based in San Francisco, CA and was founded in 2023. It was valued at $41.2 million at its seed round in Mar 2026, the last priced event on record. It has raised $13.7 million across 1 recorded round; the latest was a seed round in May 2024.
PMV mark · valuation
$41.2M
Oct 2026
Priced at
its seed round
Mar 2026
Total raised
$13.7M
Last round
Seed Round
May 2024
No prints on record
No secondary trades in ParcelBio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ParcelBio with a free account
·The complete investor list: 13 names
·Watch ParcelBio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ParcelBio stock.
